Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416935 · ClinicalTrials.gov registry record · NA
Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation
A NA study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- NA
- Development phase
- 186
- Enrollment target
NCT01416935 is a NA study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 186 participants.
The verdict
NCT01416935, a NA study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether anti arrhythmic medication, specifically Amiodarone, is required during the first three months post surgical ablation. Hypothesis: Amiodarone will not be required during the first three months as verified by no increase in rehospitalizations for recurrent Atrial Fibrillation, and report of sinus rhythm at surgical follow up (approximately 3 weeks from date of surgery), 6 weeks and 12 weeks to include patients' first follow up with cardiologist at approximately 3 months post surgery.
Interventions
- OTHER No Amiodarone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2011-01-01 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01416935
The ClinicalTrials.gov registry entry for NCT01416935 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Amiodarone is the first listed.
NCT01416935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01416935 about?
NCT01416935 is a clinical study titled "Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation". The purpose of this study is to determine whether anti arrhythmic medication, specifically Amiodarone, is required during the first three months post surgical ablation. Hypothesis: Amiodarone will not be required during the first three months as verified by no increase in rehospitalizations for rec...
What is the current status of trial NCT01416935?
This trial is currently terminated. It is a NA study. The enrollment target is 186 participants. The study started on 2011-01-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01416935?
The interventions under investigation include: No Amiodarone (OTHER).
Who is sponsoring clinical trial NCT01416935?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.